339 related articles for article (PubMed ID: 35642485)
1. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.
Kuter DJ
Haematologica; 2022 Jun; 107(6):1243-1263. PubMed ID: 35642485
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies.
Al-Samkari H; Parnes AD; Goodarzi K; Weitzman JI; Connors JM; Kuter DJ
Haematologica; 2021 Apr; 106(4):1148-1157. PubMed ID: 32499239
[TBL] [Abstract][Full Text] [Related]
3. Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.
Soff GA; Ray-Coquard I; Rivera LJM; Fryzek J; Mullins M; Bylsma LC; Park JK
PLoS One; 2022; 17(6):e0257673. PubMed ID: 35679540
[TBL] [Abstract][Full Text] [Related]
4. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention.
Degliuomini MD; Armstrong K; Mauguen A; Slotkin EK; Roberts SS; Dunkel IJ; Clouser M; Ortiz MV; Soff GA
Pediatr Blood Cancer; 2022 Oct; 69(10):e29776. PubMed ID: 35593014
[TBL] [Abstract][Full Text] [Related]
6. Romiplostim for management of chemotherapy-induced thrombocytopenia.
Parameswaran R; Lunning M; Mantha S; Devlin S; Hamilton A; Schwartz G; Soff G
Support Care Cancer; 2014 May; 22(5):1217-22. PubMed ID: 24414994
[TBL] [Abstract][Full Text] [Related]
7. Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists.
Al-Samkari H
Blood Rev; 2024 Jan; 63():101139. PubMed ID: 37914568
[TBL] [Abstract][Full Text] [Related]
8. Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
Soff GA; Miao Y; Bendheim G; Batista J; Mones JV; Parameswaran R; Wilkins CR; Devlin SM; Abou-Alfa GK; Cercek A; Kemeny NE; Sarasohn DM; Mantha S
J Clin Oncol; 2019 Nov; 37(31):2892-2898. PubMed ID: 31545663
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
[TBL] [Abstract][Full Text] [Related]
11. Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors.
Gao Y; Liu Q; Shen Y; Li Y; Shao K; Ye B; Shen Y; Zhou Y; Wu D
Platelets; 2022 Oct; 33(7):1024-1030. PubMed ID: 35040375
[TBL] [Abstract][Full Text] [Related]
12. Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis.
Gurumurthy G; Kisiel F; Gurumurthy S; Gurumurthy J
J Oncol Pharm Pract; 2023 Dec; ():10781552231219003. PubMed ID: 38155484
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytopenia in cancer patients.
Liebman HA
Thromb Res; 2014 May; 133 Suppl 2():S63-9. PubMed ID: 24862148
[TBL] [Abstract][Full Text] [Related]
14. Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
Armstrong N; Büyükkaramikli N; Penton H; Riemsma R; Wetzelaer P; Huertas Carrera V; Swift S; Drachen T; Raatz H; Ryder S; Shah D; Buksnys T; Worthy G; Duffy S; Al M; Kleijnen J
Health Technol Assess; 2020 Oct; 24(51):1-220. PubMed ID: 33108266
[TBL] [Abstract][Full Text] [Related]
15. Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy.
Soff G; Leader A; Al-Samkari H; Falanga A; Maraveyas A; Sanfilippo K; Wang TF; Zwicker J
J Thromb Haemost; 2024 Jan; 22(1):53-60. PubMed ID: 37827380
[TBL] [Abstract][Full Text] [Related]
16. Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia.
Al-Samkari H; Soff GA
Expert Rev Hematol; 2021 May; 14(5):437-448. PubMed ID: 33926362
[No Abstract] [Full Text] [Related]
17. Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Al-Samkari H; Kolb-Sielecki J; Safina SZ; Xue X; Jamieson BD
Lancet Haematol; 2022 Mar; 9(3):e179-e189. PubMed ID: 35240074
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
Hassan HT; Zander AR
J Hematother; 1996 Aug; 5(4):407-14. PubMed ID: 8877716
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.
Vadhan-Raj S
Semin Hematol; 2000 Apr; 37(2 Suppl 4):28-34. PubMed ID: 10831286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]